Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Tracking America's Recovery
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Sanofi SA
(NASDAQ:SNY)
46.55
Delayed Data
As of Mar 05
+0.65
/
+1.42%
Today’s Change
37.62
Today
|||
52-Week Range
55.00
-4.20%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest SNY News
|
Press Releases
Where Will Vaxart Be in 1 Year?
Mar 06 / MotleyFool.com - Paid Partner Content
Mario Gabelli's Gabelli Value 25 Fund 2020 Annual Shareholder Letter
Mar 01 / GuruFocus News - Paid Partner Content
Sanofi's (SNY) Dupixent sBLA for Asthma Gets FDA Acceptance
Mar 05 / Zacks.com - Paid Partner Content
Magenta Is Ready to Paint Your Portfolio Green
Feb 27 / MotleyFool.com - Paid Partner Content
Will Sanofi and GlaxoSmithKline Be Too Late to the Party With Their COVID Vaccine?
Mar 05 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: SNY/GSK & PFE COVID-19 Vaccine Update, MRK's Pandion Buyout
Feb 26 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: REGN, VIR's COVID-19 Updates, KMPH's Drug Approval & More
Mar 04 / Zacks.com - Paid Partner Content
BioMarin (BMRN) Q4 Earnings Beat, 2021 Sales View Dull
Feb 26 / Zacks.com - Paid Partner Content
Amicus' (FOLD) Q4 Earnings Miss Estimates, Sales Beat on Galafold
Mar 02 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Regulatory Updates From REGN, INCY, & Other Updates
Feb 24 / Zacks.com - Paid Partner Content
Novavax (NVAX) Loss Widens in Q4, Revenues Top Estimates
Mar 02 / Zacks.com - Paid Partner Content
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?
Feb 23 / Zacks.com - Paid Partner Content
Denali's (DNLI) Q4 Earnings & Revenues Beat on Biogen Deal
Mar 01 / Zacks.com - Paid Partner Content